Fortrea Holdings FTRE
NASDAQ FTRE
$18.24 -0.38 (-2.04%)
As of: Sep 4, 2026 · 12:49 PM EDT

Fortrea Holdings (FTRE) Change in Cash (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Change in Cash came in at $21.1 million in Q2 2026, up 203.43% YoY from $7.0 million in Q2 2025, and up 177.86% on a QoQ basis from -$27.1 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Change in Cash (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Change in Cash data on file, last reported at $21.1 million in Q2 2026.

  • Quarterly Change in Cash rose 203.43% year-over-year to $21.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $87.4 million (up 294.22% YoY) and the FY2025 annual result came in at $56.1 million, up 466.67% from the prior year.
  • Change in Cash grew to $21.1 million in Q2 2026, from -$27.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $50.1 million in Q3 2025 to a low of -$27.1 million in Q1 2026.
  • A 5-year average of $4.6 million and a median of $3.8 million in 2022 frame the typical range for Change in Cash.
  • The widest YoY moves for Change in Cash: up 459.14% in 2024, down 309.8% in 2024.
  • Tracing FTRE's Change in Cash over 5 years: stood at $2.9 million in 2022, then jumped by 65.52% to $4.8 million in 2023, then soared by 175.0% to $13.2 million in 2024, then surged by 228.03% to $43.3 million in 2025, then slumped by 51.27% to $21.1 million in 2026.
  • The last three Change in Cash figures came in at $21.1 million (Q2 2026), -$27.1 million (Q1 2026), and $43.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 374.50 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 225.59 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -37.42 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn 21.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.10 Mn
Mar 31, 2026 -27.10 Mn
Dec 31, 2025 43.30 Mn
Sep 30, 2025 50.10 Mn
Jun 30, 2025 -20.40 Mn
Mar 31, 2025 -16.90 Mn
Dec 31, 2024 13.20 Mn
Sep 30, 2024 -20.90 Mn
Jun 30, 2024 33.40 Mn
Mar 31, 2024 -15.80 Mn
Dec 31, 2023 4.80 Mn
Sep 30, 2023 -5.10 Mn
Jun 30, 2023 -9.30 Mn
Mar 31, 2023 7.80 Mn
Dec 31, 2022 2.90 Mn
Sep 30, 2022 12.00 Mn